• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Review: antidepressants do not reduce symptoms or failure to respond compared with placebo in minor depression

Question

Question: Are antidepressants and benzodiazepines effective and acceptable treatments for minor depression?

Outcomes: Depression symptoms (group mean scores or group mean change from baseline to end point on the Hamilton Rating Scale for Depression (HRSD), Montgomery-Åsberg Depression Scale (MADRS) and Clinical Global Impression (CGI) Rating Scale); failure to respond (using prespecified cut-offs on the given scales, eg, reduction <50% in HRSD or MADRS scores, not improved on the CGI); proportion of participants with major depressive disorder at the study end point (using a standardised diagnostic interview); drop-out rate.

Methods

Design: Systematic review and meta-analysis.

Data sources: MEDLINE, CINAHL, EMBASE, PsycInfo and Cochrane Controlled Trials Register. Websites of pharmaceutical companies, clinical trial registries and medical regulation agencies (eg, the US Food and Drug Administration) were used to locate additional clinical trials.

Study selection and analysis: Double-blind randomised controlled trials (RCTs) (phase III) comparing antidepressants or benzodiazepines…

Posted in: Meta-analyses - Systematic Reviews on 08/21/2011 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice